HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing ...

This makes it a promising candidate for treating diseases that rely on IgG-mediated immune responses. The implications of this discovery extend far beyond MG. IgG-mediated pathologies—from ...

People with Crohn's disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or ...

The relationship between food allergies and chronic illness represents one of the most significant yet underappreciated ...

“However, the immune system, if given appropriate signals, can be modulated towards providing an appropriate, efficacious, and lasting disease-modifying immunoglobulin G (IgG)-mediated response ...

COVID-19 has little impact on patients with dermatological immune-mediated inflammatory diseases, with effective ...

(RTTNews) - Johnson & Johnson (JNJ), on Thursday announced the publication of new data on nipocalimab, an investigational drug designed to treat IgG-driven alloantibody and autoantibody diseases.

including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as ...

ADCC is a cell-mediated ... than those of IgG in healthy individuals. Clinically, however, IgE levels rise dramatically in type I hypersensitivity reactions, including allergic diseases like ...

NEW HAVEN, CT, USA I March 3, 2025 I Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...